Il-1 receptor antagonist (il-1ra) levels and management of metabolic disorders

HIGHLIGHTS

• who: Kari Luotola from the Faculty of Medicine, Clinicum, University of Helsinki and Helsinki University Hospital, Haartmaninkatu , have published the Article: IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders, in the Journal: Nutrients 2022, 14, 3422. of /2022/
• how: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Boards.
• future: Future research may evaluate the role of IL-1Ra in actual glucose homeostasis together with routine fasted laboratory tests such as glucose and C-reactive protein (CRP) instead of the oral . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.